rituximab
US/ɹɪˈtʌk.sɪˌmæb/
rituximab noun: a chimeric monoclonal antibody (trademark Rituxan) administered by intravenous injection especially to treat non-Hodgkin lymphoma and chronic lymphocytic leukemia by binding to the protein CD20 found on the surface of B cells and causing their lysis.
Noun
rituximab (usually uncountable, plural rituximabs)
- A chimeric monoclonal antibody (trademark Rituxan) administered by intravenous injection especially to treat non-Hodgkin lymphoma and chronic lymphocytic leukemia by binding to the protein CD20 found on the surface of B cells and causing their lysis.
Forms of rituximab
| plural | rituximabs |
|---|---|
| alternative form | IDEC-C2B8 |
Origin of rituximab
From [Term?] + -tu- (“tumor”) + -ximab (“chimeric monoclonal antibody”).
Questions about rituximab
- What does rituximab mean?
- Rituximab means a chimeric monoclonal antibody (trademark Rituxan) administered by intravenous injection especially to treat non-Hodgkin lymphoma and chronic lymphocytic leukemia by binding to the protein CD20 found on the surface of B cells and causing their lysis.
- What part of speech is rituximab?
- Rituximab is a noun.
- How do you pronounce rituximab?
- Rituximab is pronounced /ɹɪˈtʌk.sɪˌmæb/ (US).
- What is the plural of rituximab?
- The plural of rituximab is rituximabs.
Words near rituximab in the dictionary
Source and license
Adapted from Wiktionary: rituximab (page history and authors). Text available under the Creative Commons Attribution-ShareAlike 4.0 license. Word.ws reformatted the entry and added links. Wiktionary data of 2026-09-02.
Last updated:
Cite this entry: “rituximab.” Word.ws, https://word.ws/rituximab. Based on Wiktionary, CC BY-SA 4.0.
